Works matching AU Kong, Lan

Results: 119
    1
    2
    3
    4

    The D<sub>1</sub>/D<sub>5</sub> Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study.

    Published in:
    Journal of Parkinson's Disease, 2020, v. 10, n. 4, p. 1515, doi. 10.3233/JPD-202188
    By:
    • Huang, Xuemei;
    • Lewis, Mechelle M.;
    • Van Scoy, Lauren Jodi;
    • De Jesus, Sol;
    • Eslinger, Paul J.;
    • Arnold, Amy C.;
    • Miller, Amanda J.;
    • Fernandez-Mendoza, Julio;
    • Snyder, Bethany;
    • Harrington, William;
    • Kong, Lan;
    • Wang, Xi;
    • Sun, Dongxiao;
    • Delnomdedieu, Marielle;
    • Duvvuri, Sridhar;
    • Mahoney, Susan E.;
    • Gray, David L.;
    • Mailman, Richard B.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    History of smoking and olfaction in Parkinson's disease.

    Published in:
    Movement Disorders, 2014, v. 29, n. 8, p. 1069, doi. 10.1002/mds.25912
    By:
    • Lucassen, Elisabeth B.;
    • Sterling, Nicholas W.;
    • Lee, Eun‐Young;
    • Chen, Honglei;
    • Lewis, Mechelle M.;
    • Kong, Lan;
    • Huang, Xuemei
    Publication type:
    Article
    26
    27
    28

    Low plasma serotonin linked to higher nigral iron in Parkinson's disease.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03700-2
    By:
    • Jellen, Leslie C.;
    • Lewis, Mechelle M.;
    • Du, Guangwei;
    • Wang, Xi;
    • Galvis, Martha L. Escobar;
    • Krzyzanowski, Stanislaw;
    • Capan, Colt D.;
    • Snyder, Amanda M.;
    • Connor, James. R.;
    • Kong, Lan;
    • Mailman, Richard B.;
    • Brundin, Patrik;
    • Brundin, Lena;
    • Huang, Xuemei
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder.

    Published in:
    Addiction Science & Clinical Practice, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13722-024-00481-7
    By:
    • Freet, Christopher S.;
    • Evans, Brianna;
    • Brick, Timothy R.;
    • Deneke, Erin;
    • Wasserman, Emily J.;
    • Ballard, Sarah M.;
    • Stankoski, Dean M.;
    • Kong, Lan;
    • Raja-Khan, Nazia;
    • Nyland, Jennifer E.;
    • Arnold, Amy C.;
    • Krishnamurthy, Venkatesh Basappa;
    • Fernandez-Mendoza, Julio;
    • Cleveland, H. Harrington;
    • Scioli, Adam D.;
    • Molchanow, Amanda;
    • Messner, Amy E.;
    • Ayaz, Hasan;
    • Grigson, Patricia S.;
    • Bunce, Scott C.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Engineering Online and In-Person Social Networks for Physical Activity: A Randomized Trial.

    Published in:
    2016
    By:
    • Rovniak, Liza;
    • Kong, Lan;
    • Hovell, Melbourne;
    • Ding, Ding;
    • Sallis, James;
    • Ray, Chester;
    • Kraschnewski, Jennifer;
    • Matthews, Stephen;
    • Kiser, Elizabeth;
    • Chinchilli, Vernon;
    • George, Daniel;
    • Sciamanna, Christopher;
    • Rovniak, Liza S;
    • Hovell, Melbourne F;
    • Sallis, James F;
    • Ray, Chester A;
    • Kraschnewski, Jennifer L;
    • Matthews, Stephen A;
    • Chinchilli, Vernon M;
    • George, Daniel R
    Publication type:
    journal article
    50